Urinary tract infection
Not recruitingStudy on the Safety and Effectiveness of a UTI Vaccine (GSKVX000000046019) for Adults Aged 18-64 and Women Aged 18-64 with Urinary Tract Infections
Study on the Safety and Effectiveness of a UTI Vaccine (GSKVX000000046019) for Adults Aged 18-64 and Women Aged 18-64 with Urinary Tract Infections
- Disease:Urinary tract infection
- Substances:GSKVX000000044501GSKVX000000046019
Belgium- Participants:18–64 years · Healthy volunteers
- Substances:GSKVX000000044501
- Sponsor:GlaxoSmithKline Biologicals









